Could less treatment time be just as effective for fighting leukemia?
NCT ID NCT07437950
Summary
This study is for adults aged 60 or older with newly diagnosed acute myeloid leukemia (AML) who are less fit for intensive chemotherapy. It compares two treatment schedules combining the same three oral medications. The goal is to see if taking one of the drugs for 14 days per cycle is as effective as taking it for 28 days, which could mean fewer side effects and a better quality of life for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.